Terms: = Liver cancer AND SBDS, SWDS, 51119, ENSG00000126524, FLJ10917, CGI-97, Q9Y3A5 AND Treatment
2 results:
1. FCN3 inhibits the progression of hepatocellular carcinoma by suppressing sbds-mediated blockade of the p53 pathway.
Ma D; Liu P; Wen J; Gu Y; Yang Z; Lan J; Fan H; Liu Z; Guo D
Int J Biol Sci; 2023; 19(2):362-376. PubMed ID: 36632465
[TBL] [Abstract] [Full Text] [Related]
2. The thrombopoietin/MPL axis is activated in the Gata1
Zingariello M; Sancillo L; Martelli F; Ciaffoni F; Marra M; Varricchio L; Rana RA; Zhao C; Crispino JD; Migliaccio AR
Blood Cancer J; 2017 Jun; 7(6):e572. PubMed ID: 28622305
[TBL] [Abstract] [Full Text] [Related]
